Richmond Pharmacology

Clinical Research Services

Leading Expertise

 

The combination of the MHRA Accreditation and the expert knowledge of conducting 500
Early Phase Studies ensure Richmond Pharmacology can provide you with a service that meets your needs.

 

 
     
 

 

  • Adaptive Phase I Studies

    Rapid approval, flexible conduct, government agency accredited facility, experienced


  • TQT Studies

    Unique all under one roof setting, world-class specialist clinic and core laboratory


  • Bridging Studies

    Longstanding European specialist provider of Japanese and Japanese Bridging studies since 2002


  • Patient Recruitment

    Innovative record breaking specialist early phase patient recruitment

MEET THE EXPERTS

Richmond Pharmacology's people have extensive knowledge and expertise.

Experts

PUBLICATIONS

 

View our latest
peer-reviewed
publications


View Publications Publications

LATEST VIDEOS

 

Learn more about Richmond
Pharmacology by viewing
some of our videos


Watch VideosVideos
© 2017 Richmond Pharmacology  |  disclaimer  |  Corporate Accounts  |  site map
Paid Clinical Trials


Thorough QT (TQT) Richmond Pharmacology is one of the leading providers of TQT studies. All TQT studies performed at Richmond Pharmacology are in collaboration with Professor Camm, Head of Cardiac and Vascular Sciences, St George's University of London, a world renowned opinion leader in cardiological analysis, providing a one stop solution unique in the field of contract research.

 

Richmond Pharmacology provide technical expertise for all your QTc study needs from study design, clinical conduct, ECG data management, QTc measurement and analysis, through to the final study report.

 

There are three essential components to any clinical study assessing the effects on the QT interval:

1) The clinical recording of ECGs

2) The measurement and verification of measurements

3) The statistical analysis of potential effects

 

Of these three it is essential that the clinical recording of the ECG’s are performed to the highest standard as this provides the foundation for successful completion of the other two components.

 

Richmond Pharmacology’s innovative approach to the conduct of TQT studies has reduced the variability rates allowing one to reduce the overall costs. In-house expertise and past experience makes Richmond Pharmacology the ideal partner for performing definitive TQT studies, all under one roof.